ID

32931

Description

Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00975065

Link

https://clinicaltrials.gov/show/NCT00975065

Keywords

  1. 11/20/18 11/20/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 20, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT00975065

Eligibility Type 2 Diabetes Mellitus NCT00975065

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes mellitus who were inadequately controlled (baseline a1c of 7.0~11.0%)on metformin monotherapy (1500mg metformin)for ≥ 2 months before baseline visit
Description

Non-Insulin-Dependent Diabetes Mellitus Poorly controlled | Hemoglobin A1c measurement | Metformin Dosage

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C3853134
UMLS CUI [2]
C0474680
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
age of 18-80 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
body mass index of 18-40 kg/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 of diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
myocardial infarction, unstable angina, or coronary artery bypass graft within the previous 6 months
Description

Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0010055
congestive heart failure (iii or nyha class iv)
Description

Congestive heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
liver disease such as cirrhosis or chronic active hepatitis
Description

Liver disease | Liver Cirrhosis | Hepatitis, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0023890
UMLS CUI [3]
C0019189
history of lacticacidemia
Description

Lactic acidemia

Data type

boolean

Alias
UMLS CUI [1]
C0347959
use of any oral anti-diabetic drug other than metformin within the 2 months
Description

Antidiabetics Oral | Exception Metformin

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
use of insulin before screening visit
Description

Insulin

Data type

boolean

Alias
UMLS CUI [1]
C0021641
alt or ast >3 times the upper limit of normal range
Description

Alanine aminotransferase increased | Aspartate aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0151905
UMLS CUI [2]
C0151904
creatinine >1.5 mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
other situation (pregnant or lactating females, history of drug or alcohol abuse, night-shift workers, clinically significant laboratory abnormality on screening or any medical condition that would affect the completion or outcome of the study)
Description

Pregnancy | Breast Feeding | Substance Use Disorders | Night shift worker | Laboratory test result abnormal | Medical condition Affecting Completion of clinical trial | Medical condition Affecting Research results

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0038586
UMLS CUI [4]
C0555008
UMLS CUI [5]
C0438215
UMLS CUI [6,1]
C3843040
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C2732579
UMLS CUI [7,1]
C3843040
UMLS CUI [7,2]
C0392760
UMLS CUI [7,3]
C0683954

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00975065

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Poorly controlled | Hemoglobin A1c measurement | Metformin Dosage
Item
patients with type 2 diabetes mellitus who were inadequately controlled (baseline a1c of 7.0~11.0%)on metformin monotherapy (1500mg metformin)for ≥ 2 months before baseline visit
boolean
C0011860 (UMLS CUI [1,1])
C3853134 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Age
Item
age of 18-80 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index of 18-40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 of diabetes
boolean
C0011854 (UMLS CUI [1])
Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery
Item
myocardial infarction, unstable angina, or coronary artery bypass graft within the previous 6 months
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
Congestive heart failure New York Heart Association Classification
Item
congestive heart failure (iii or nyha class iv)
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Liver disease | Liver Cirrhosis | Hepatitis, Chronic
Item
liver disease such as cirrhosis or chronic active hepatitis
boolean
C0023895 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])
Lactic acidemia
Item
history of lacticacidemia
boolean
C0347959 (UMLS CUI [1])
Antidiabetics Oral | Exception Metformin
Item
use of any oral anti-diabetic drug other than metformin within the 2 months
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Insulin
Item
use of insulin before screening visit
boolean
C0021641 (UMLS CUI [1])
Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
alt or ast >3 times the upper limit of normal range
boolean
C0151905 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatinine >1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Pregnancy | Breast Feeding | Substance Use Disorders | Night shift worker | Laboratory test result abnormal | Medical condition Affecting Completion of clinical trial | Medical condition Affecting Research results
Item
other situation (pregnant or lactating females, history of drug or alcohol abuse, night-shift workers, clinically significant laboratory abnormality on screening or any medical condition that would affect the completion or outcome of the study)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0038586 (UMLS CUI [3])
C0555008 (UMLS CUI [4])
C0438215 (UMLS CUI [5])
C3843040 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C2732579 (UMLS CUI [6,3])
C3843040 (UMLS CUI [7,1])
C0392760 (UMLS CUI [7,2])
C0683954 (UMLS CUI [7,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial